Comparison of standard-dose and half-dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis
2014 ◽
Vol 45
(6)
◽
pp. 2295-2302
◽
2020 ◽
Vol 35
(10)
◽
pp. 1774-1781
◽
2016 ◽
Vol 20
(12)
◽
pp. 2063-2073
◽
2020 ◽
Vol 43
(11)
◽
pp. 1608-1618
◽